The so-called universal CDx approved by the FDA can gauge alterations across multiple genes associated with response to three lung cancer treatments.
Guardant is alleging that Foundation's advertising of its own products has harmed both Guardant and cancer patients.
BGI is currently awaiting final approval for the offering from the China Securities Regulatory Commission.
A study focused on rare CNVs unearthed a subset of Tourette cases affected by deletions in the NRXN1 gene or duplications in the CNTN6 gene.
Euroimmun is a global leader in autoimmune testing and an emerging force in infectious disease and allergy testing, according to PerkinElmer.
DuPont Pioneer has acquired the exclusive rights to ERS Genomics' portfolio of CRISPR-Cas genome-editing technologies for all plant and agricultural applications.
The International Mouse Phenotyping Consortium has systematically studied knockout mice to find new disease models and candidate disease genes.
At the WIN Symposium, a Merck executive detailed how data from a basket study led to the first pan-cancer, biomarker-informed cancer drug.
The UCSF Helen Diller Family Comprehensive Cancer Center has installed GenomOncology's GO Clinical Workbench to support the institution's UCSF500 NGS panel.
A company hopes to capture the genetic diversity in India to power tailored therapeutics, BBC News reports.
Researchers tie variants in seven genes to insomnia risk, Live Science reports.
The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.
In PLOS this week: locus near OAS1 linked to Sjogren's syndrome, rotavirus reassortment events uncovered by sequencing, and more.